Treatment-emergent neuroendocrine prostate cancer with a germline BRCA2 mutation: identification of a candidate reversion mutation associated with platinum/PARP-inhibitor resistance.
Cold Spring Harbor Molecular Case Studies
Pandya, Deep D; Shah, Myra M; Kaplan, Fuat F; Martino, Candice C; Levy, Gillian G; Kazanjian, Mia M; Batter, Stephen S; Martignetti, John J; Frank, Richard C RC